KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) EBIT Margin (2016 - 2026)

Staar Surgical's EBIT Margin history spans 17 years, with the latest figure at 89.27% for Q1 2026.

  • For Q1 2026, EBIT Margin rose 12441.0% year-over-year to 89.27%; the TTM value through Jan 2026 reached 7.21%, down 661.0%, while the annual FY2026 figure was 7.21%, 661.0% down from the prior year.
  • EBIT Margin reached 89.27% in Q1 2026 per STAA's latest filing, up from 19.52% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 89.27% in Q1 2026 to a low of 174.24% in Q4 2022.
  • Average EBIT Margin over 5 years is 13.89%, with a median of 7.13% recorded in 2024.
  • Peak YoY movement for EBIT Margin: crashed -18676bps in 2022, then soared 16033bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 174.24% in 2022, then soared by 92bps to 13.92% in 2023, then tumbled by -152bps to 35.14% in 2024, then surged by 156bps to 19.52% in 2025, then soared by 357bps to 89.27% in 2026.
  • Per Business Quant, the three most recent readings for STAA's EBIT Margin are 89.27% (Q1 2026), 19.52% (Q3 2025), and 67.61% (Q2 2025).